0001104659-21-075843.txt : 20210602
0001104659-21-075843.hdr.sgml : 20210602
20210602172209
ACCESSION NUMBER: 0001104659-21-075843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blakeman Shaun M.
CENTRAL INDEX KEY: 0001776592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31337
FILM NUMBER: 21990258
MAIL ADDRESS:
STREET 1: C/O CANTEL MEDICAL CORP.
STREET 2: 150 CLOVE ROAD
CITY: LITTLE FALLS
STATE: NJ
ZIP: 07424
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CANTEL MEDICAL CORP
CENTRAL INDEX KEY: 0000019446
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221760285
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: OVERLOOK AT GREAT NOTCH
STREET 2: 150 CLOVE ROAD
CITY: LITTLE FALLS
STATE: NJ
ZIP: 07424
BUSINESS PHONE: 973-890-7220
MAIL ADDRESS:
STREET 1: OVERLOOK AT GREAT NOTCH
STREET 2: 150 CLOVE ROAD
CITY: LITTLE FALLS
STATE: NJ
ZIP: 07424
FORMER COMPANY:
FORMER CONFORMED NAME: CANTEL INDUSTRIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: STENDIG INDUSTRIES INC
DATE OF NAME CHANGE: 19890425
FORMER COMPANY:
FORMER CONFORMED NAME: CHARVOZ CARSEN CORP
DATE OF NAME CHANGE: 19861215
4
1
tm2118222-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-02
1
0000019446
CANTEL MEDICAL CORP
CMD
0001776592
Blakeman Shaun M.
150 CLOVE ROAD
LITTLE FALLS
NJ
07424
0
1
0
0
SVP - CFO
Common Stock, par value $.10 per share
2021-06-02
4
D
0
13953
80.59
D
0
D
Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59. and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
/s/ Shaun M. Blakeman
2021-06-02